Press release
PHARMANOVIA EXPANDS EXCLUSIVE LICENSING COLLABORATION WITH AQUESTIVE THERAPEUTICS FOR DIAZEPAM BUCCAL FILM
March 30, 2023Business Services
Basildon, UK – For immediate release, 27 March 2023 Pharmanovia, a global pharmaceutical company that revitalises, extends and expands …
Unite Health: Thousands Honor Pandemic ‘Influencers’ Through COVID-19 Social Media Awards
March 30, 2023Business Services
London, UK | In a global display of appreciation, thousands of people are recognizing social media influencers who used …
Vaccitech Announces Positive Topline Final Data for HBV002 Study in People with Chronic Hepatitis B
March 28, 2023Business Services
OXFORD, United Kingdom, March 28, 2023 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company focused on the …
Newron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatry
March 28, 2023Business Services
Milan, Italy, March 28, 2023, 12:30 pm CET – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company …
TEZSPIRE▼(TEZEPELUMAB) TO BE RECOMMENDED BY NICE AS AN ADD-ON TREATMENT FOR SEVERE UNCONTROLLED ASTHMA
March 28, 2023Business Services
London, UK, Tuesday 28 March 2023 – AstraZeneca today announced that the National Institute for Health and Care Excellence (NICE) …
Tavneos® (avacopan) included in updated EULAR recommendations for the management of AAV
March 28, 2023Business Services
ST. GALLEN, Switzerland, March 28, 2023 /PRNewswire/ — Vifor Fresenius Medical Care Renal Pharma (VFMCRP) is pleased to announce that …
iOnctura awarded UK’s MHRA Innovation Passport for entry into innovative licensing and access pathway (ILAP)
March 28, 2023Business Services
Geneva, Switzerland and Amsterdam, The Netherlands, 28 March – iOnctura, a clinical stage biotechnology company developing breakthrough therapies for patients …
Sofinnova Partners launches Digital Medicine Strategy
March 28, 2023Business Services
PARIS, France – March 28, 2023 – Sofinnova Partners (“Sofinnova”), a leading European life sciences venture capital firm based in …
Vantage Nutrition LLC acquires ComboCap Inc
March 28, 2023Business Services
Vantage Nutrition, an ACG group company announces full shareholding ownership of ComboCap Inc (USA) and BioCap (South Africa).
Particle Works partners with Earli Inc. to develop DNA-LNPs for early-stage cancer treatment
March 27, 2023Business Services
Particle Works, a leading provider of innovative microfluidic nanoparticle synthesis platforms, is supporting Earli Inc. in its mission to detect, …
Revolo Biotherapeutics Announces Completion of Phase 2a Trial of ‘1104 in Allergic Disease
March 27, 2023Business Services
NEW ORLEANS, LA and CAMBRIDGE, England, March 27, 2023 – Revolo Biotherapeutics (“Revolo Bio” or the “Company”), a company developing …
Statement Following Jounce Therapeutics Announcement of a Definitive Merger Agreement with Concentra Biosciences and Withdrawal of their Recommendation for the Business Combination with Redx
March 27, 2023Business Services
Alderley Park, UK 27 March 2023 Redx Pharma (“Redx”, AIM: REDX), the clinical-stage biotechnology company focused on discovering and developing …
MHRA Grants Conditional Marketing Authorisation in Great Britain to CSL’s HEMGENIX® (etranacogene dezaparvovec) as First Gene Therapy for Haemophilia B
March 27, 2023Business Services
This medicine is subject to additional monitoring.This will allow quick identification of new safety information.
Avacta to present pre-clinical data on AVA3996 at the American Association for Cancer Research Annual Meeting
March 27, 2023Business Services
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces it will …
Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS
March 27, 2023Business Services
Leiden, The Netherlands, March 24, 2023: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that the …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
